Clip
Enhancing Creativity through Psilocybin
1:44:03 - 1:49:30 (05:27)
Research has shown that microdosing psilocybin can enhance activation of the serotonergic pathways, specifically the 5HT2A receptor, in the brain and can lead to an enhancement of both divergent and convergent creative thinking.
Similar Clips
Microdosing psychedelics such as psilocybin could have therapeutic benefits for disorders such as ADHD and anxiety, but more double-blind research is needed to differentiate the effects from a placebo.
1:45:57 - 1:50:21 (04:24)
Summary
Microdosing psychedelics such as psilocybin could have therapeutic benefits for disorders such as ADHD and anxiety, but more double-blind research is needed to differentiate the effects from a placebo. However, there may be a potential overlap between therapeutic use and positive psychology in terms of improving mood and focus.
ChapterThe Science of Psychedelics
EpisodeDr. Matthew Johnson: Psychedelics for Treating Mental Disorders
PodcastHuberman Lab
MDMA may have potential as an empathogen for increasing connection and awareness, but caution is advised for individuals under 25 years old or those who struggle with mental health disorders.
1:03:20 - 1:05:23 (02:03)
Summary
MDMA may have potential as an empathogen for increasing connection and awareness, but caution is advised for individuals under 25 years old or those who struggle with mental health disorders.
ChapterThe Negative Effects of Alcohol and Cold Exposure After Workouts
EpisodeEp. 151 | 2 Bears 1 Cave w/ Tom Segura & Bert Kreischer
Podcast2 Bears, 1 Cave with Tom Segura & Bert Kreischer
The potential cumulative negative effects of microdosing psychedelics through serotonin 5-HT2B receptor or other mechanisms require careful consideration for physical and psychological safety in the context of research, but there is low concern for toxicity or cardiotoxicity with therapeutic usage of psychedelics a few times in a lifetime.
1:54:43 - 1:57:06 (02:23)
Summary
The potential cumulative negative effects of microdosing psychedelics through serotonin 5-HT2B receptor or other mechanisms require careful consideration for physical and psychological safety in the context of research, but there is low concern for toxicity or cardiotoxicity with therapeutic usage of psychedelics a few times in a lifetime.
ChapterMicrodosing Psychedelics for Depression: Potential or Risks?
EpisodeDr. Matthew Johnson: Psychedelics for Treating Mental Disorders
PodcastHuberman Lab
The speaker discusses their human research with Schedule 1 and 2 drugs, such as psilocybin, methamphetamine, and cocaine, and explains the regulations and lack of restrictions for certain drugs and caffeine products.
1:18:30 - 1:20:26 (01:55)
Summary
The speaker discusses their human research with Schedule 1 and 2 drugs, such as psilocybin, methamphetamine, and cocaine, and explains the regulations and lack of restrictions for certain drugs and caffeine products.
ChapterThe Consequence of Raising the Price of Addictive Products
Episode#145 – Matthew Johnson: Psychedelics
PodcastLex Fridman Podcast
The impact of trazodone on neurotransmitter levels varies depending on the specific neurotransmitter.
2:43:57 - 2:47:58 (04:01)
Summary
The impact of trazodone on neurotransmitter levels varies depending on the specific neurotransmitter. Trazodone primarily affects histamine levels while also having a lesser impact on noradrenaline and serotonin levels.